3KCG - JenaLib

Asym./Biol. Unit (Jmol Viewer)

Asym./Biol. Unit - sites (Jmol Viewer)

Title :   CRYSTAL STRUCTURE OF THE ANTITHROMBIN-FACTOR IXA-PENTASACCHARIDE COMPLEX

Authors :   J. A. Huntington, D. J. D. Johnson

Date :   21 Oct 09 (Deposition) - 02 Feb 10 (Release) - 02 Feb 10 (Revision)

Method :   X-RAY DIFFRACTION

Resolution :   1.70

Chains :   Asym./Biol. Unit : H,I,L

Keywords :   Michaelis Complex, Blood Coagulation, Calcium, Disulfide Bond, Egf-Like Domain, Glycoprotein, Hemophilia, Hydrolase, Pharmaceutical, Protease, Secreted, Serine Protease, Sulfation, Zymogen, Heparin-Binding, Protease Inhibitor, Serine Protease Inhibitor, Thrombophilia (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   D. J. Johnson, J. Langdown, J. A. Huntington
Molecular Basis Of Factor Ixa Recognition By Heparin-Activated Antithrombin Revealed By A 1. 7-A Structure Of The Ternary Complex.
Proc. Natl. Acad. Sci. Usa V. 107 645 2010
PubMed-ID: 20080729 | Reference-DOI: 10.1073/PNAS.0910144107

Molecule 1 - COAGULATION FACTOR IXA LIGHT CHAIN
	Chains	:	L
	EC Number	:	3.4.21.22
	Engineered	:	YES
	Expression System	:	ESCHERICHIA COLI
	Expression System Taxid	:	562
	Fragment	:	EGF2
	Gene	:	F9
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606
	Synonym	:	FACTOR IX, CHRISTMAS FACTOR, PLASMA THROMBOPLASTIN COMPONENT, PTC

Molecule 2 - COAGULATION FACTOR IXA HEAVY CHAIN
	Chains	:	H
	EC Number	:	3.4.21.22
	Engineered	:	YES
	Expression System	:	ESCHERICHIA COLI
	Expression System Taxid	:	562
	Gene	:	F9
	Mutation	:	YES
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606
	Synonym	:	FACTOR IX, CHRISTMAS FACTOR, PLASMA THROMBOPLASTIN COMPONENT, PTC

Molecule 3 - ANTITHROMBIN-III
	Chains	:	I
	Engineered	:	YES
	Expression System Cell	:	BHK
	Gene	:	SERPINC1, AT3, PRO0309
	Mutation	:	YES
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606
	Synonym	:	ATIII

		1	2	3
Asymmetric/Biological Unit	:	H	I	L

Summary Information (see also Sequences/Alignments below)

Asymmetric/Biological Unit (6, 11)

No.	Name	Count	Type	Full Name
1	CA	1	Ligand/Ion	CALCIUM ION
2	FUC	2	Ligand/Ion	ALPHA-L-FUCOSE
3	MAN	1	Ligand/Ion	ALPHA-D-MANNOSE
4	MPD	2	Ligand/Ion	(4S)-2-METHYL-2,4-PENTANEDIOL
5	NAG	4	Ligand/Ion	N-ACETYL-D-GLUCOSAMINE
6	NTP	1	Ligand/Ion	HEPARIN PENTASACCHARIDE

Asymmetric Unit (11, 11)

No.	Name	Evidence	Residues	Description
01	AC1	SOFTWARE	GLU H:70 , ASN H:72 , GLU H:75 , GLU H:77 , GLU H:80 , HOH H:267	BINDING SITE FOR RESIDUE CA H 500
02	AC2	SOFTWARE	ASN I:96 , HOH I:476 , FUC I:802	BINDING SITE FOR RESIDUE NAG I 801
03	AC3	SOFTWARE	NAG I:801	BINDING SITE FOR RESIDUE FUC I 802
04	AC4	SOFTWARE	ASN I:18 , PRO I:19 , MET I:20 , ASN I:155 , THR I:157 , HOH I:519 , HOH I:637 , HOH I:749 , HOH I:750 , HOH I:751 , NAG I:842	BINDING SITE FOR RESIDUE NAG I 841
05	AC5	SOFTWARE	ASN I:18 , THR I:157 , NAG I:841 , MAN I:843	BINDING SITE FOR RESIDUE NAG I 842
06	AC6	SOFTWARE	NAG I:842	BINDING SITE FOR RESIDUE MAN I 843
07	AC7	SOFTWARE	ASN I:192 , HOH I:639 , FUC I:902	BINDING SITE FOR RESIDUE NAG I 901
08	AC8	SOFTWARE	LYS I:193 , NAG I:901	BINDING SITE FOR RESIDUE FUC I 902
09	AC9	SOFTWARE	HIS H:91 , HIS H:92 , ASN H:93 , ASN H:100 , HIS H:101 , ASN H:178 , ASN H:179 , ARG H:233 , ASN H:236 , HOH H:284 , HOH H:315 , HOH H:346 , HOH H:378 , HOH H:452 , LYS I:11 , PRO I:12 , ARG I:13 , ALA I:43 , THR I:44 , ASN I:45 , ARG I:47 , VAL I:48 , SER I:112 , GLU I:113 , LYS I:114 , PHE I:122 , LYS I:125 , ARG I:129 , HOH I:434 , HOH I:447 , HOH I:478 , HOH I:516 , HOH I:517 , HOH I:541 , HOH I:629 , HOH I:631 , HOH I:730 , HOH I:744	BINDING SITE FOR RESIDUE NTP I 433
10	BC1	SOFTWARE	ASN I:127 , LEU I:130 , LEU I:140 , SER I:142 , ILE I:219 , HOH I:527 , HOH I:530 , MPD I:5277	BINDING SITE FOR RESIDUE MPD I 5276
11	BC2	SOFTWARE	ALA I:124 , VAL I:165 , TYR I:166 , GLY I:167 , MPD I:5276	BINDING SITE FOR RESIDUE MPD I 5277

Asymmetric/Biological Unit

No.	Residues
1	H:42	-	H:58
2	H:168	-	H:182
3	H:191	-	H:220
4	I:8	-	I:128
5	I:21	-	I:95
6	I:247	-	I:430
7	L:88	-	L:99
8	L:95	-	L:109
9	L:111	-	L:124
10	L:132	-	H:122

(no "Cis Peptide Bond" information available for 3KCG)

Asymmetric/Biological Unit (179, 179)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
001	UniProt	VAR_007033	I	39	N	ANT3_HUMAN	Disease (AT3D)	28929468	I	I	7	N
002	UniProt	VAR_006573	V	227	D	FA9_HUMAN	Disease (HEMB)	---	H	V	16	D
003	UniProt	VAR_017310	V	227	F	FA9_HUMAN	Disease (HEMB)	137852242	H	V	16	F
004	UniProt	VAR_017311	V	228	F	FA9_HUMAN	Disease (HEMB)	137852243	H	V	17	F
005	UniProt	VAR_006574	V	228	L	FA9_HUMAN	Disease (HEMB)	137852243	H	V	17	L
006	UniProt	VAR_007034	M	52	T	ANT3_HUMAN	Unclassified	---	I	M	20	T
007	UniProt	VAR_071199	C	53	F	ANT3_HUMAN	Disease (AT3D)	---	I	C	21	F
008	UniProt	VAR_007035	R	56	C	ANT3_HUMAN	Disease (AT3D)	28929469	I	R	24	C
009	UniProt	VAR_006575	Q	241	H	FA9_HUMAN	Disease (HEMB)	---	H	Q	30	H
010	UniProt	VAR_017352	Q	241	K	FA9_HUMAN	Disease (HEMB)	---	H	Q	30	K
011	UniProt	VAR_007036	P	73	L	ANT3_HUMAN	Disease (AT3D)	121909551	I	P	41	L
012	UniProt	VAR_017312	C	252	S	FA9_HUMAN	Disease (HEMB)	267606792	H	C	42	S
013	UniProt	VAR_017353	C	252	Y	FA9_HUMAN	Disease (HEMB)	---	H	C	42	Y
014	UniProt	VAR_006576	G	253	E	FA9_HUMAN	Disease (HEMB)	---	H	G	43	E
015	UniProt	VAR_006577	G	253	R	FA9_HUMAN	Disease (HEMB)	---	H	G	43	R
016	UniProt	VAR_007037	R	79	C	ANT3_HUMAN	Disease (AT3D)	121909547	I	R	47	C
017	UniProt	VAR_007038	R	79	H	ANT3_HUMAN	Disease (AT3D)	121909552	I	R	47	H
018	UniProt	VAR_007039	R	79	S	ANT3_HUMAN	Disease (AT3D)	121909547	I	R	47	S
019	UniProt	VAR_006578	A	265	T	FA9_HUMAN	Disease (HEMB)	---	H	A	55	T
020	UniProt	VAR_007041	R	89	C	ANT3_HUMAN	Disease (AT3D)	147266200	I	R	57	C
021	UniProt	VAR_007042	F	90	L	ANT3_HUMAN	Disease (AT3D)	---	I	F	58	L
022	UniProt	VAR_017313	C	268	W	FA9_HUMAN	Disease (HEMB)	137852246	H	C	58	W
023	UniProt	VAR_027452	Y	95	C	ANT3_HUMAN	Disease (AT3D)	---	I	Y	63	C
024	UniProt	VAR_012316	Y	95	S	ANT3_HUMAN	Disease (AT3D)	---	I	Y	63	S
025	UniProt	VAR_027453	L	98	P	ANT3_HUMAN	Disease (AT3D)	---	I	L	66	P
026	UniProt	VAR_006579	A	279	T	FA9_HUMAN	Disease (HEMB)	137852247	H	A	68	T
027	UniProt	VAR_006580	N	283	D	FA9_HUMAN	Disease (HEMB)	---	H	N	72	D
028	UniProt	VAR_007044	P	112	T	ANT3_HUMAN	Disease (AT3D)	---	I	P	80	T
029	UniProt	VAR_017314	E	291	V	FA9_HUMAN	Disease (HEMB)	137852279	H	E	80	V
030	UniProt	VAR_006582	R	294	G	FA9_HUMAN	Disease (HEMB)	---	H	R	83	G
031	UniProt	VAR_006583	R	294	Q	FA9_HUMAN	Disease (HEMB)	137852249	H	R	83	Q
032	UniProt	VAR_073980	V	296	M	FA9_HUMAN	Unclassified (HEMB)	---	H	V	85	M
033	UniProt	VAR_017349	C	134	Y	FA9_HUMAN	Disease (HEMB)	---	L	C	88	Y
034	UniProt	VAR_027454	M	121	K	ANT3_HUMAN	Disease (AT3D)	---	I	M	89	K
035	UniProt	VAR_006560	I	136	T	FA9_HUMAN	Disease (HEMB)	---	L	I	90	T
036	UniProt	VAR_006584	H	302	R	FA9_HUMAN	Disease (HEMB)	---	H	H	91	R
037	UniProt	VAR_073978	N	138	H	FA9_HUMAN	Unclassified (HEMB)	---	L	N	92	H
038	UniProt	VAR_006561	G	139	D	FA9_HUMAN	Disease (HEMB)	---	L	G	93	D
039	UniProt	VAR_071200	G	125	D	ANT3_HUMAN	Disease (AT3D)	---	I	G	93	D
040	UniProt	VAR_006562	G	139	S	FA9_HUMAN	Disease (HEMB)	---	L	G	93	S
041	UniProt	VAR_027455	C	127	R	ANT3_HUMAN	Disease (AT3D)	121909573	I	C	95	R
042	UniProt	VAR_017315	N	306	S	FA9_HUMAN	Disease (HEMB)	137852251	H	N	95	S
043	UniProt	VAR_007045	L	131	F	ANT3_HUMAN	Disease (AT3D)	121909567	I	L	99	F
044	UniProt	VAR_007046	L	131	V	ANT3_HUMAN	Disease (AT3D)	---	I	L	99	V
045	UniProt	VAR_007047	Q	133	K	ANT3_HUMAN	Disease (AT3D)	---	I	Q	101	K
046	UniProt	VAR_006585	I	316	F	FA9_HUMAN	Disease (HEMB)	---	H	I	103	F
047	UniProt	VAR_017354	L	318	R	FA9_HUMAN	Disease (HEMB)	---	H	L	105	R
048	UniProt	VAR_006586	L	321	Q	FA9_HUMAN	Disease (HEMB)	---	H	L	108	Q
049	UniProt	VAR_006563	C	155	F	FA9_HUMAN	Disease (HEMB)	---	L	C	109	F
050	UniProt	VAR_006564	G	160	E	FA9_HUMAN	Disease (HEMB)	---	L	G	114	E
051	UniProt	VAR_027456	K	146	E	ANT3_HUMAN	Disease (AT3D)	---	I	K	114	E
052	UniProt	VAR_013085	T	147	A	ANT3_HUMAN	Polymorphism	2227606	I	T	115	A
053	UniProt	VAR_073981	N	328	K	FA9_HUMAN	Unclassified (HEMB)	---	H	N	115	K
054	UniProt	VAR_073982	N	328	Y	FA9_HUMAN	Disease (HEMB)	---	H	N	115	Y
055	UniProt	VAR_007049	S	148	P	ANT3_HUMAN	Disease (AT3D)	121909569	I	S	116	P
056	UniProt	VAR_007050	Q	150	P	ANT3_HUMAN	Disease (AT3D)	765445413	I	Q	118	P
057	UniProt	VAR_006587	P	333	H	FA9_HUMAN	Disease (HEMB)	---	H	P	120	H
058	UniProt	VAR_017355	P	333	T	FA9_HUMAN	Disease (HEMB)	---	H	P	120	T
059	UniProt	VAR_007051	H	152	Y	ANT3_HUMAN	Disease (AT3D)	---	I	H	120	Y
060	UniProt	VAR_006565	Q	167	H	FA9_HUMAN	Disease (HEMB)	---	L	Q	121	H
061	UniProt	VAR_017350	S	169	C	FA9_HUMAN	Disease (HEMB)	---	L	S	123	C
062	UniProt	VAR_017351	C	170	F	FA9_HUMAN	Disease (HEMB)	---	L	C	124	F
063	UniProt	VAR_007053	L	158	P	ANT3_HUMAN	Disease (AT3D)	---	I	L	126	P
064	UniProt	VAR_027457	C	160	Y	ANT3_HUMAN	Disease (AT3D)	---	I	C	128	Y
065	UniProt	VAR_006588	T	342	K	FA9_HUMAN	Disease (HEMB)	---	H	T	129	K
066	UniProt	VAR_006589	T	342	M	FA9_HUMAN	Disease (HEMB)	137852254	H	T	129	M
067	UniProt	VAR_007054	R	161	Q	ANT3_HUMAN	Disease (AT3D)	121909563	I	R	129	Q
068	UniProt	VAR_006566	C	178	R	FA9_HUMAN	Disease (HEMB)	---	L	C	132	R
069	UniProt	VAR_006567	C	178	W	FA9_HUMAN	Disease (HEMB)	---	L	C	132	W
070	UniProt	VAR_012750	N	167	T	ANT3_HUMAN	Polymorphism	121909570	I	N	135	T
071	UniProt	VAR_006590	G	351	D	FA9_HUMAN	Disease (HEMB)	---	H	G	136	D
072	UniProt	VAR_071201	S	170	P	ANT3_HUMAN	Disease (AT3D)	---	I	S	138	P
073	UniProt	VAR_006591	W	356	C	FA9_HUMAN	Disease (HEMB)	---	H	W	141	C
074	UniProt	VAR_006592	G	357	E	FA9_HUMAN	Disease (HEMB)	137852275	H	G	142	E
075	UniProt	VAR_017316	G	357	R	FA9_HUMAN	Disease (HEMB)	137852257	H	G	142	R
076	UniProt	VAR_027458	L	178	H	ANT3_HUMAN	Disease (AT3D)	---	I	L	146	H
077	UniProt	VAR_027459	F	179	L	ANT3_HUMAN	Disease (AT3D)	---	I	F	147	L
078	UniProt	VAR_006593	K	362	E	FA9_HUMAN	Disease (HEMB)	---	H	K	148	E
079	UniProt	VAR_006594	G	363	W	FA9_HUMAN	Disease (HEMB)	---	H	G	149	W
080	UniProt	VAR_006595	A	366	D	FA9_HUMAN	Disease (HEMB)	---	H	A	152	D
081	UniProt	VAR_007055	Y	190	C	ANT3_HUMAN	Polymorphism	---	I	Y	158	C
082	UniProt	VAR_006596	R	379	G	FA9_HUMAN	Disease (HEMB)	---	H	R	165	G
083	UniProt	VAR_006597	R	379	Q	FA9_HUMAN	Disease (HEMB)	137852259	H	R	165	Q
084	UniProt	VAR_007056	Y	198	C	ANT3_HUMAN	Disease (AT3D)	---	I	Y	166	C
085	UniProt	VAR_027460	Y	198	H	ANT3_HUMAN	Disease (AT3D)	---	I	Y	166	H
086	UniProt	VAR_006598	C	382	Y	FA9_HUMAN	Disease (HEMB)	---	H	C	168	Y
087	UniProt	VAR_017358	L	383	F	FA9_HUMAN	Disease (HEMB)	---	H	L	169	F
088	UniProt	VAR_017357	L	383	I	FA9_HUMAN	Disease (HEMB)	---	H	L	169	I
089	UniProt	VAR_062999	R	384	L	FA9_HUMAN	Disease (THPH8)	137852283	H	R	170	L
090	UniProt	VAR_006599	K	387	E	FA9_HUMAN	Disease (HEMB)	---	H	K	173	E
091	UniProt	VAR_006600	I	390	F	FA9_HUMAN	Disease (HEMB)	---	H	I	176	F
092	UniProt	VAR_006601	M	394	K	FA9_HUMAN	Disease (HEMB)	---	H	M	180	K
093	UniProt	VAR_017359	F	395	I	FA9_HUMAN	Disease (HEMB)	---	H	F	181	I
094	UniProt	VAR_017360	F	395	L	FA9_HUMAN	Disease (HEMB)	---	H	F	181	L
095	UniProt	VAR_017361	C	396	F	FA9_HUMAN	Disease (HEMB)	---	H	C	182	F
096	UniProt	VAR_027461	S	214	F	ANT3_HUMAN	Disease (AT3D)	---	I	S	182	F
097	UniProt	VAR_006602	C	396	S	FA9_HUMAN	Disease (HEMB)	137852273	H	C	182	S
098	UniProt	VAR_007057	S	214	Y	ANT3_HUMAN	Disease (AT3D)	483352854	I	S	182	Y
099	UniProt	VAR_017317	A	397	P	FA9_HUMAN	Disease (HEMB)	137852281	H	A	183	P
100	UniProt	VAR_071202	I	218	N	ANT3_HUMAN	Disease (AT3D)	---	I	I	186	N
101	UniProt	VAR_007059	N	219	D	ANT3_HUMAN	Disease (AT3D)	121909571	I	N	187	D
102	UniProt	VAR_007058	N	219	K	ANT3_HUMAN	Disease (AT3D)	---	I	N	187	K
103	UniProt	VAR_027463	S	223	P	ANT3_HUMAN	Disease (AT3D)	121909572	I	S	191	P
104	UniProt	VAR_017362	C	407	R	FA9_HUMAN	Disease (HEMB)	---	H	C	191	R
105	UniProt	VAR_006604	C	407	S	FA9_HUMAN	Disease (HEMB)	---	H	C	191	S
106	UniProt	VAR_017318	D	410	H	FA9_HUMAN	Disease (HEMB)	137852278	H	D	194	H
107	UniProt	VAR_017320	S	411	G	FA9_HUMAN	Disease (HEMB)	137852277	H	A	195	G
108	UniProt	VAR_017319	S	411	I	FA9_HUMAN	Disease (HEMB)	137852276	H	A	195	I
109	UniProt	VAR_017363	G	412	E	FA9_HUMAN	Disease (HEMB)	---	H	G	196	E
110	UniProt	VAR_006605	G	413	R	FA9_HUMAN	Disease (HEMB)	---	H	G	197	R
111	UniProt	VAR_017321	P	414	T	FA9_HUMAN	Disease (HEMB)	137852265	H	P	198	T
112	UniProt	VAR_006606	V	419	E	FA9_HUMAN	Disease (HEMB)	137852280	H	V	203	E
113	UniProt	VAR_006607	F	424	V	FA9_HUMAN	Disease (HEMB)	---	H	F	208	V
114	UniProt	VAR_006608	T	426	P	FA9_HUMAN	Disease (HEMB)	---	H	T	210	P
115	UniProt	VAR_027464	T	243	I	ANT3_HUMAN	Disease (AT3D)	---	I	T	211	I
116	UniProt	VAR_006609	S	430	T	FA9_HUMAN	Disease (HEMB)	---	H	S	214	T
117	UniProt	VAR_006610	W	431	G	FA9_HUMAN	Disease (HEMB)	---	H	W	215	G
118	UniProt	VAR_006611	W	431	R	FA9_HUMAN	Disease (HEMB)	---	H	W	215	R
119	UniProt	VAR_071203	V	248	G	ANT3_HUMAN	Disease (AT3D)	---	I	V	216	G
120	UniProt	VAR_006612	G	432	S	FA9_HUMAN	Disease (HEMB)	---	H	G	216	S
121	UniProt	VAR_006613	G	432	V	FA9_HUMAN	Disease (HEMB)	---	H	G	216	V
122	UniProt	VAR_006614	E	433	A	FA9_HUMAN	Disease (HEMB)	---	H	E	217	A
123	UniProt	VAR_006615	E	433	K	FA9_HUMAN	Disease (HEMB)	767828752	H	E	217	K
124	UniProt	VAR_027465	I	251	T	ANT3_HUMAN	Disease (AT3D)	---	I	I	219	T
125	UniProt	VAR_017364	C	435	Y	FA9_HUMAN	Disease (HEMB)	---	H	C	220	Y
126	UniProt	VAR_006616	A	436	V	FA9_HUMAN	Disease (HEMB)	137852266	H	A	221	V
127	UniProt	VAR_027466	W	257	R	ANT3_HUMAN	Disease (AT3D)	---	I	W	225	R
128	UniProt	VAR_017365	G	442	E	FA9_HUMAN	Disease (HEMB)	---	H	G	226	E
129	UniProt	VAR_017322	G	442	R	FA9_HUMAN	Disease (HEMB)	137852267	H	G	226	R
130	UniProt	VAR_017323	I	443	T	FA9_HUMAN	Disease (HEMB)	137852268	H	I	227	T
131	UniProt	VAR_027467	F	261	L	ANT3_HUMAN	Disease (AT3D)	---	I	F	229	L
132	UniProt	VAR_006618	R	449	Q	FA9_HUMAN	Disease (HEMB)	143018900	H	R	233	Q
133	UniProt	VAR_006619	R	449	W	FA9_HUMAN	Disease (HEMB)	757996262	H	R	233	W
134	UniProt	VAR_006620	Y	450	C	FA9_HUMAN	Disease (HEMB)	---	H	Y	234	C
135	UniProt	VAR_007060	E	269	K	ANT3_HUMAN	Disease (AT3D)	758087836	I	E	237	K
136	UniProt	VAR_017324	W	453	R	FA9_HUMAN	Disease (HEMB)	137852269	H	W	237	R
137	UniProt	VAR_006621	I	454	T	FA9_HUMAN	Disease (HEMB)	---	H	I	238	T
138	UniProt	VAR_014308	T	461	P	FA9_HUMAN	Polymorphism	4149751	H	T	245	P
139	UniProt	VAR_007062	M	283	I	ANT3_HUMAN	Disease (AT3D)	---	I	M	251	I
140	UniProt	VAR_027468	M	283	V	ANT3_HUMAN	Disease (AT3D)	---	I	M	251	V
141	UniProt	VAR_071204	R	293	P	ANT3_HUMAN	Disease (AT3D)	---	I	R	261	P
142	UniProt	VAR_007063	L	302	P	ANT3_HUMAN	Disease (AT3D)	---	I	L	270	P
143	UniProt	VAR_007064	I	316	N	ANT3_HUMAN	Disease (AT3D)	---	I	I	284	N
144	UniProt	VAR_027469	S	323	P	ANT3_HUMAN	Disease (AT3D)	---	I	S	291	P
145	UniProt	VAR_007065	E	334	K	ANT3_HUMAN	Disease (AT3D)	---	I	E	302	K
146	UniProt	VAR_007067	S	381	P	ANT3_HUMAN	Disease (AT3D)	121909565	I	S	349	P
147	UniProt	VAR_007068	R	391	Q	ANT3_HUMAN	Polymorphism	201541724	I	R	359	Q
148	UniProt	VAR_027470	S	397	P	ANT3_HUMAN	Disease (AT3D)	---	I	S	365	P
149	UniProt	VAR_027471	D	398	H	ANT3_HUMAN	Disease (AT3D)	---	I	D	366	H
150	UniProt	VAR_071205	H	401	R	ANT3_HUMAN	Disease (AT3D)	---	I	H	369	R
151	UniProt	VAR_027472	S	412	R	ANT3_HUMAN	Disease (AT3D)	---	I	S	380	R
152	UniProt	VAR_007069	A	414	T	ANT3_HUMAN	Disease (AT3D)	121909557	I	A	382	T
153	UniProt	VAR_007070	A	416	P	ANT3_HUMAN	Disease (AT3D)	28930978	I	A	384	P
154	UniProt	VAR_007071	A	416	S	ANT3_HUMAN	Disease (AT3D)	121909548	I	A	384	S
155	UniProt	VAR_007072	A	419	V	ANT3_HUMAN	Disease (AT3D)	121909568	I	A	387	V
156	UniProt	VAR_007073	G	424	D	ANT3_HUMAN	Disease (AT3D)	121909566	I	G	392	D
157	UniProt	VAR_007075	R	425	C	ANT3_HUMAN	Disease (AT3D)	121909554	I	R	393	C
158	UniProt	VAR_007074	R	425	H	ANT3_HUMAN	Disease (AT3D)	121909549	I	R	393	H
159	UniProt	VAR_007076	R	425	P	ANT3_HUMAN	Disease (AT3D)	121909549	I	R	393	P
160	UniProt	VAR_007077	S	426	L	ANT3_HUMAN	Disease (AT3D)	121909550	I	S	394	L
161	UniProt	VAR_007078	F	434	C	ANT3_HUMAN	Disease (AT3D)	---	I	F	402	C
162	UniProt	VAR_007080	F	434	L	ANT3_HUMAN	Disease (AT3D)	---	I	F	402	L
163	UniProt	VAR_007079	F	434	S	ANT3_HUMAN	Disease (AT3D)	---	I	F	402	S
164	UniProt	VAR_007081	A	436	T	ANT3_HUMAN	Disease (AT3D)	121909546	I	A	404	T
165	UniProt	VAR_007082	N	437	K	ANT3_HUMAN	Disease (AT3D)	---	I	N	405	K
166	UniProt	VAR_009258	R	438	G	ANT3_HUMAN	Disease (AT3D)	---	I	R	406	G
167	UniProt	VAR_007083	R	438	M	ANT3_HUMAN	Disease (AT3D)	---	I	R	406	M
168	UniProt	VAR_071206	P	439	A	ANT3_HUMAN	Disease (AT3D)	---	I	P	407	A
169	UniProt	VAR_007084	P	439	L	ANT3_HUMAN	Disease (AT3D)	121909555	I	P	407	L
170	UniProt	VAR_007085	P	439	T	ANT3_HUMAN	Disease (AT3D)	---	I	P	407	T
171	UniProt	VAR_027473	L	441	P	ANT3_HUMAN	Disease (AT3D)	---	I	L	409	P
172	UniProt	VAR_007086	I	453	T	ANT3_HUMAN	Disease (AT3D)	---	I	I	421	T
173	UniProt	VAR_007087	G	456	R	ANT3_HUMAN	Disease (AT3D)	---	I	G	424	R
174	UniProt	VAR_007088	R	457	T	ANT3_HUMAN	Disease (AT3D)	---	I	R	425	T
175	UniProt	VAR_007090	A	459	D	ANT3_HUMAN	Disease (AT3D)	---	I	A	427	D
176	UniProt	VAR_007091	P	461	L	ANT3_HUMAN	Disease (AT3D)	121909564	I	P	429	L
177	UniProt	VAR_007092	C	462	F	ANT3_HUMAN	Disease (AT3D)	---	I	C	430	F
178	UniProt	VAR_017356	I	344	L	FA9_HUMAN	Disease (HEMB)	---	H	I	129B	L
179	UniProt	VAR_006603	R	404	T	FA9_HUMAN	Disease (HEMB)	---	H	R	188A	T

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Asymmetric/Biological Unit (5, 5)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	EGF_2	PS01186	EGF-like domain signature 2.	FA9_HUMAN	117-128 155-170	1	- L:109-124
2	TRYPSIN_DOM	PS50240	Serine proteases, trypsin domain profile.	FA9_HUMAN	227-459	1	H:16-243
3	TRYPSIN_HIS	PS00134	Serine proteases, trypsin family, histidine active site.	FA9_HUMAN	263-268	1	H:53-58
4	TRYPSIN_SER	PS00135	Serine proteases, trypsin family, serine active site.	FA9_HUMAN	405-416	1	H:189-200
5	SERPIN	PS00284	Serpins signature.	ANT3_HUMAN	434-444	1	I:402-412

Asymmetric/Biological Unit (11, 12)

	ENSEMBL					UniProtKB			PDB
No.	Transcript ID	Exon	Exon ID	Genome Location	Length	ID	Location	Length	Count	Location	Length
1.1b	ENST00000218099	1b	ENSE00002195519	X:138612917-138613011	95	FA9_HUMAN	1-30	30	0	-	-
1.2b	ENST00000218099	2b	ENSE00000677287	X:138619169-138619332	164	FA9_HUMAN	30-84	55	0	-	-
1.3	ENST00000218099	3	ENSE00001173335	X:138619521-138619545	25	FA9_HUMAN	85-93	9	0	-	-
1.4a	ENST00000218099	4a	ENSE00001173327	X:138623235-138623348	114	FA9_HUMAN	93-131	39	1	- L:84-85	- 2
1.5b	ENST00000218099	5b	ENSE00001173320	X:138630522-138630650	129	FA9_HUMAN	131-174	44	1	- L:85-128	- 44
1.6	ENST00000218099	6	ENSE00001173315	X:138633221-138633423	203	FA9_HUMAN	174-241	68	2	H:16-30 L:128-137	15 10
1.7	ENST00000218099	7	ENSE00001173311	X:138642900-138643014	115	FA9_HUMAN	242-280	39	1	H:31-69 (gaps) -	40 -
1.8b	ENST00000218099	8b	ENSE00001029145	X:138643683-138645617	1935	FA9_HUMAN	280-461	182	1	H:69-245 (gaps) -	184 -

2.1a	ENST00000367698	1a	ENSE00001944151	chr1:173886516-173886357	160	ANT3_HUMAN	1-14	14	0	-	-
2.3a	ENST00000367698	3a	ENSE00000814673	chr1:173884057-173883691	367	ANT3_HUMAN	14-136	123	1	I:3-104 (gaps)	102
2.4c	ENST00000367698	4c	ENSE00000789910	chr1:173881152-173880937	216	ANT3_HUMAN	137-208	72	1	I:105-176	72
2.5a	ENST00000367698	5a	ENSE00000789909	chr1:173880029-173879892	138	ANT3_HUMAN	209-254	46	1	I:177-222	46
2.6b	ENST00000367698	6b	ENSE00000789908	chr1:173879080-173878690	391	ANT3_HUMAN	255-385	131	1	I:223-353	131
2.7a	ENST00000367698	7a	ENSE00001383315	chr1:173876652-173876588	65	ANT3_HUMAN	385-406	22	1	I:353-374	22
2.8a	ENST00000367698	8a	ENSE00001876994	chr1:173873203-173872947	257	ANT3_HUMAN	407-464	58	1	I:375-431	57

Asymmetric/Biological Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain H from PDB  Type:PROTEIN  Length:235
 aligned with FA9_HUMAN | P00740 from UniProtKB/Swiss-Prot  Length:461

    Alignment length:235
                                   236       246       256       266       276       286       296       306       316       326       336       346       356       366       376       386       396       406       416       426       436       446       456     
           FA9_HUMAN    227 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKFTIYNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTKLT  461
               SCOP domains d3kcgh_ H: Coagulation factor IXa, protease domain                                                                                                                                                                                          SCOP domains
               CATH domains 3kcgH01     3kcgH02 H:28-120,H:233-245 Trypsin-like serine proteases                                       3kcgH01 H:16-27,H:121-232 Trypsin-like serine proteases                                                            3kcgH02       CATH domains
               Pfam domains Trypsin-3kcgH01 H:16-238                                                                                                                                                                                                            ------- Pfam domains
         Sec.struct. author ....ee........eeeee......eeeeeee..eeeehhhhh......eeee............eeeeeeeeee....hhhhh......eeeee................hhhhhhhhhh..eeeeee..............eeeeeeeehhhhhhh.........eeee................eeeeee..eeeeeeeeeee.........eeeee...hhhhhhhhhh.. Sec.struct. author
             SAPs(SNPs) (1) DF------------H----------SE-----------T--W----------T---D-------V--G-M-----R---S---------F-R--Q------K----H--------K-L------D----CE----EW--D------------G--YFL--E--F---KIFP------T--R--HGERT----E----V-P---TGSA-YV-----ET-----QC--RT------P SAPs(SNPs) (1)
             SAPs(SNPs) (2) FL------------K----------YR----------------------------------------Q---------------------------------Y----T--------M--------------R---------------------Q---I-----------LS----------S---I-------------------RVK--------R------W------------ SAPs(SNPs) (2)
                PROSITE (1) TRYPSIN_DOM  PDB: H:16-243 UniProt: 227-459                                                                                                                                                                                              -- PROSITE (1)
                PROSITE (2) ------------------------------------TRYPSI----------------------------------------------------------------------------------------------------------------------------------------TRYPSIN_SER --------------------------------------------- PROSITE (2)
           Transcript 1 (1) Exon 1.6       Exon 1.7  PDB: H:31-69 (gaps)          ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript 1 (1)
           Transcript 1 (2) -----------------------------------------------------Exon 1.8b  PDB: H:69-245 (gaps) UniProt: 280-461                                                                                                                                       Transcript 1 (2)
                3kcg H   16 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKFTIYNNMFCAGFHEGGRDSCQGDAGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTKLT  245
                                    25        35||      46        56    |   65        75        85        95||     103       113       123      |131       141   ||  152       162       172       182  |    190       200       210      |221|      230       240     
                                               36|                    60A                                 95A|                               129A|             145|                                  184A 188A                          217|  |                        
                                                38                                                         95B                                129B              147                                                                      219  |                        
                                                                                                                                                                                                                                           221A

Chain I from PDB  Type:PROTEIN  Length:419
 aligned with ANT3_HUMAN | P01008 from UniProtKB/Swiss-Prot  Length:464

    Alignment length:429
                                    44        54        64        74        84        94       104       114       124       134       144       154       164       174       184       194       204       214       224       234       244       254       264       274       284       294       304       314       324       334       344       354       364       374       384       394       404       414       424       434       444       454         
          ANT3_HUMAN     35 SPVDICTAKPRDIPMNPMCIYRSPEKKATEDEGSEQKIPEATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCV  463
               SCOP domains d3kcgi_ I: Antithrombin                                                                                                                                                                                                                                                                                                                                                                                                                       SCOP domains
               CATH domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains --------------------------------------------------Serpin-3kcgI01 I:53-429                                                                                                                                                                                                                                                                                                                                                                  -- Pfam domains
         Sec.struct. author ...hhhhh.................----------.......hhhhhhhhhhhhhhhhhhhhhhhhhh.....eeehhhhhhhhhhhhhh..hhhhhhhhhhhh.....hhhhhhhhhhhhhhhhhhhhhhhh..eeeeeeeeeeee.....hhhhhhhhhhhhh...eeehhhhhhhhhhhhhhhhhhhhh..................eeeeeeeeeee......hhhhheeeeee.....eeeeeeeeeeeeeeeee.hhh.eeeeee.....eeeeeee.....hhhhhhhh.hhhhhhhhhhhheeeeeeeeee.eeeeeeeehhhhhhhh..hhhhh....................eeeeeeeeee...............ee.......eeee....eeeeeee....eeeeeeee..... Sec.struct. author
             SAPs(SNPs) (1) ----N------------TF--C----------------L-----C---------CL----C--P-------------T--------K---D-R---F-K------------EAP-P-Y-----P-YQ-----T--P-------HL----------C-------C---------------F---ND---P-------------------I----G--T-----R---L-------K-------------I---------P--------P-------------N------P----------K----------------------------------------------P---------Q-----PH--R----------R-T-P--V----DCL-------C-TKGA-P-----------T--RT-D-LF- SAPs(SNPs) (1)
             SAPs(SNPs) (2) --------------------------------------------H---------------S-----------------------------------V------------------------------------------------------------------H---------------Y----K---------------------------------------------------------------V------------------------------------------------------------------------------------------------------------------------------------S--------H--------L---ML------------------------ SAPs(SNPs) (2)
             SAPs(SNPs) (3) --------------------------------------------S---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------P--------S----T------------------------ SAPs(SNPs) (3)
                PROSITE (2) ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------SERPIN     ------------------- PROSITE (2)
           Transcript 2 (1) Exon 2.3a  PDB: I:3-104 (gaps) UniProt: 14-136 [INCOMPLETE]                                           Exon 2.4c  PDB: I:105-176 UniProt: 137-208                              Exon 2.5a  PDB: I:177-222 UniProt: 209-254    Exon 2.6b  PDB: I:223-353 UniProt: 255-385                                                                                         ---------------------Exon 2.8a  PDB: I:375-431 UniProt: 407-464 [INCOMPLETE]   Transcript 2 (1)
           Transcript 2 (2) --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 2.7a             --------------------------------------------------------- Transcript 2 (2)
                3kcg I    3 SPVDICTAKPRDIPMNPMCIYRSPE----------QKIPEATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCV  431
                                    12        22    |    -     |  42        52        62        72        82        92       102       112       122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       302       312       322       332       342       352       362       372       382       392       402       412       422         
                                                   27         38

Chain L from PDB  Type:PROTEIN  Length:54
 aligned with FA9_HUMAN | P00740 from UniProtKB/Swiss-Prot  Length:461

    Alignment length:54
                                   139       149       159       169       179    
           FA9_HUMAN    130 LDVTCNIKNGRCEQFCKNSADNKVVCSCTEGYRLAENQKSCEPAVPFPCGRVSV  183
               SCOP domains d3kcgl_ L: Factor IX (IXa)                             SCOP domains
               CATH domains 3kcgL00 L:84-137 Laminin                               CATH domains
               Pfam domains ------------------------------------------------------ Pfam domains
         Sec.struct. author ......hhhhhh..eeee.....eeee....eee......eee........... Sec.struct. author
             SAPs(SNPs) (1) ----Y-T-HD---------------F----E------H-CF-------R----- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ---------S--------------------------------------W----- SAPs(SNPs) (2)
                PROSITE (1) -------------------------EGF_2           ------------- PROSITE (1)
                PROSITE (2) ------------------------------------------------------ PROSITE (2)
           Transcript 1 (1) 1.------------------------------------------Exon 1.6   Transcript 1 (1)
           Transcript 1 (2) -Exon 1.5b  PDB: L:85-128 UniProt: 131-174   --------- Transcript 1 (2)
                3kcg L   84 MDVTCNIKNGRCEQFCKNSADNKVVCSCTEGYRLAENQKSCEPAVPFPCGRVSV  137
                                    93       103       113       123       133

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Asymmetric/Biological Unit

Classes(

)

Architectures( (-)

)

Topologies( (-)

)

Homologous Superfamilies( (-)

)

Organisms( (-)

)

Class: Mainly Beta (13760)

Architecture: Beta Barrel (4804)

Topology: Thrombin, subunit H (1535)

Homologous Superfamily: Trypsin-like serine proteases (1488)

Human (Homo sapiens) (615)

1a	3kcgH01	H:16-27,H:121-232
1b	3kcgH02	H:28-120,H:233-245

Architecture: Ribbon (789)

Topology: Laminin (270)

Homologous Superfamily: Laminin (263)

Human (Homo sapiens) (195)

3kcgL00

L:84-137

Asymmetric/Biological Unit

Clans(

)

Families(

)

Organisms( (-)

)

Clan: Peptidase_PA (797)

Family: Trypsin (679)

Homo sapiens (Human) (339)

Trypsin-3kcgH01

H:16-238

Clan: no clan defined [family: Serpin] (63)

Family: Serpin (63)

Homo sapiens (Human) (41)

Serpin-3kcgI01

I:53-429

Asymmetric/Biological Unit(hide GO term definitions)

Chain H,L (FA9_HUMAN | P00740)

molecular function
	GO:0005509	calcium ion binding	Interacting selectively and non-covalently with calcium ions (Ca2+).
	GO:0004175	endopeptidase activity	Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain.
	GO:0016787	hydrolase activity	Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
	GO:0046872	metal ion binding	Interacting selectively and non-covalently with any metal ion.
	GO:0008233	peptidase activity	Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.
	GO:0004252	serine-type endopeptidase activity	Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
	GO:0008236	serine-type peptidase activity	Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
biological process
	GO:0006888	ER to Golgi vesicle-mediated transport	The directed movement of substances from the endoplasmic reticulum (ER) to the Golgi, mediated by COP II vesicles. Small COP II coated vesicles form from the ER and then fuse directly with the cis-Golgi. Larger structures are transported along microtubules to the cis-Golgi.
	GO:0007596	blood coagulation	The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
	GO:0007598	blood coagulation, extrinsic pathway	A protein activation cascade that contributes to blood coagulation and consists of the self-limited process linking exposure and activation of tissue factor to the activation of clotting factor X.
	GO:0007597	blood coagulation, intrinsic pathway	A protein activation cascade that contributes to blood coagulation and consists of the interactions among high molecular weight kininogen, prekallikrein, and factor XII that lead to the activation of clotting factor X.
	GO:0007599	hemostasis	The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.
	GO:0017187	peptidyl-glutamic acid carboxylation	The gamma-carboxylation of peptidyl-glutamic acid; catalyzed by the vitamin K dependent gamma-glutamyl carboxylase.
	GO:0006508	proteolysis	The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
	GO:0006465	signal peptide processing	The proteolytic removal of a signal peptide from a protein during or after transport to a specific location in the cell.
	GO:0031638	zymogen activation	The proteolytic processing of an inactive enzyme to an active form.
cellular component
	GO:0005796	Golgi lumen	The volume enclosed by the membranes of any cisterna or subcompartment of the Golgi apparatus, including the cis- and trans-Golgi networks.
	GO:0005788	endoplasmic reticulum lumen	The volume enclosed by the membranes of the endoplasmic reticulum.
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Chain I (ANT3_HUMAN | P01008)

molecular function
	GO:0008201	heparin binding	Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
	GO:0030414	peptidase inhibitor activity	Stops, prevents or reduces the activity of a peptidase, any enzyme that catalyzes the hydrolysis peptide bonds.
	GO:0002020	protease binding	Interacting selectively and non-covalently with any protease or peptidase.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0004867	serine-type endopeptidase inhibitor activity	Stops, prevents or reduces the activity of serine-type endopeptidases, enzymes that catalyze the hydrolysis of nonterminal peptide bonds in a polypeptide chain; a serine residue (and a histidine residue) are at the active center of the enzyme.
biological process
	GO:0007596	blood coagulation	The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
	GO:0007599	hemostasis	The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.
	GO:0010951	negative regulation of endopeptidase activity	Any process that decreases the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins.
	GO:0050728	negative regulation of inflammatory response	Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.
	GO:0010466	negative regulation of peptidase activity	Any process that stops or reduces the rate of peptidase activity, the hydrolysis of peptide bonds within proteins.
	GO:2000266	regulation of blood coagulation, intrinsic pathway	Any process that modulates the frequency, rate or extent of blood coagulation, intrinsic pathway.
	GO:0007584	response to nutrient	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus.
cellular component
	GO:0072562	blood microparticle	A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Asymmetric/Biological Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		CA	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		FUC	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		MAN	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		MPD	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		NAG	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		NTP	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]
		AC3	[ RasMol ]	+environment [ RasMol ]
		AC4	[ RasMol ]	+environment [ RasMol ]
		AC5	[ RasMol ]	+environment [ RasMol ]
		AC6	[ RasMol ]	+environment [ RasMol ]
		AC7	[ RasMol ]	+environment [ RasMol ]
		AC8	[ RasMol ]	+environment [ RasMol ]
		AC9	[ RasMol ]	+environment [ RasMol ]
		BC1	[ RasMol ]	+environment [ RasMol ]
		BC2	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
(no "Cis Peptide Bonds" information available for 3kcg)

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ Asym./Biol. Unit PNG format \| Asym./Biol. Unit - sites PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	3kcg
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	ANT3_HUMAN \| P01008
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt
	FA9_HUMAN \| P00740
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	3.4.21.22
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	300807
		Disease Information	:	OMIM
	306900
		Disease Information	:	OMIM
	613118
		Disease Information	:	OMIM

Access by GenAge ID
	(no 'GenAge ID' available)
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	ANT3_HUMAN \| P01008
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)
	FA9_HUMAN \| P00740
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

(no "Related Entries Specified in the PDB File" available for 3KCG)

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (6, 11)

Sites (11, 11)

SS Bonds (10, 10)

Cis Peptide Bonds (0, 0)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (179, 179)

PROSITE Motifs (5, 5)

Exons (11, 12)

Sequences/Alignments

Classification and Annotation

SCOP Domains (3, 3)

CATH Domains (2, 3)

Pfam Domains (2, 2)

Gene Ontology (33, 39)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File